[Labelling meproscillarin with tritium at the C-19 position (author's transl)].
Labelling of 14-hydroxy-3beta-[4-O-methyl-alpha-L-rhamnopyranosyl)oxy]-14beta-bufa-4,20,22-trienolide (meproscillarin, Clift) by introduction of dueterium and tritium at the metabolically stable C-19 position is described.
D002301:Cardiac Glycosides; D055598:Chemical Phenomena; D002621:Chemistry; D003903:Deuterium; D004355:Drug Stability; D007553:Isotope Labeling; D008722:Methods; D014316:Tritium
D002301:Cardiac Glycosides; D014316:Tritium; D003903:Deuterium
Radioaktive Markierung von Meproscillarin in der C-19-Methylgruppe mit Tritium.